Projects per year
- 1 - 50 out of 81 results
Search results
-
Acupuncture Trial
Niravath, P. A., Chang, J. C., Heyne, K., Mai, H. P., Singh, M. & Sun, K.
Project: Clinical Trial
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
A Nanodrug for the Cure of Metastatic Breast Cancer
Chang, J. C., Ensor, Jr., J. E. & Liu, X.
7/15/17 → 3/1/20
Project: Federal Funding Agencies
-
A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Aromatase in Obese Subjects (CTMS# 15-2100)
Niravath, P. A., Chang, J. C. & Darcourt, J.
12/1/16 → 11/30/18
Project: Federal Funding Agencies
-
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Mai, H. P., Chang, J. C., Niravath, P. A. & Sun, K.
Project: Clinical Trial
-
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
6/10/22 → 5/31/27
Project: Federal Funding Agencies
-
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Templeton, S., Arentz, C., Chang, J. C., Darcourt, J., Dubrovsky, E., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Niravath, P. A., Abdelrahim, M., Arentz, C., Chang, J. C., Heyne, K. & Singh, M.
Project: Clinical Trial
-
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Chang, J. C., Darcourt, J., Geyer, C. E. & Niravath, P. A.
Project: Clinical Trial
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative
Niravath, P. A., Butler, E. B., Chang, J. C., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B. & Teh, B. S.
Project: Clinical Trial
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit
-
A simple assay system for rapid detection of circulating tumor cells.
9/25/14 → 9/24/16
Project: Federal Funding Agencies
-
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Sun, K., Chang, J. C., Mai, H. P., Niravath, P. A. & Templeton, S.
Project: Clinical Trial
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy
Chang, J. C. & Rosato, R. R.
9/12/17 → 8/31/20
Project: Federal Funding Agencies
-
BO41843: Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Niravath, P. A., Chang, J. C., Mai, H. P. & Sun, K.
Project: Clinical Trial
-
Brain Metastases Registry
Rostomily, R. C., Baskin, D. S., Bernicker, E. H., Britz, G. W., Butler, E. B., Chang, J. C., Farach, A. M., Fung, S. H. & Teh, B. S.
Project: Clinical Trial
-
Center of Excellence for Individualization of Therapy for Breast Cancer
10/1/10 → 3/31/12
Project: Federal Funding Agencies
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial
-
Contractor shall provide certain breast health screening and diagnostic services
4/1/22 → 4/1/24
Project: Non Profit
-
Convergent AI for Precise Breast Cancer Risk Assessment
Wong, S. T., Chang, J. C. & Ensor, Jr., J. E.
6/1/20 → 5/31/25
Project: Federal Funding Agencies
-
Converting HR+ Breast Cancer Into an Individualized Vaccine
Chang, J. C., Darcourt, J. & Niravath, P. A.
9/30/19 → 9/30/23
Project: Federal Funding Agencies
-
Converting HR Breast Cancer Into an Individualized Vaccine
Chang, J. C., Mai, H. P., Niravath, P. A. & Sun, K.
Project: Clinical Trial
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
Developing Effective Therapies for ER-negative Breast Cancer Using Genomics and Proteomics
Univ of Texas MD Anderson Cancer Center
12/8/10 → 7/31/15
Project: Non Profit
-
Dual targeting of PI3K and NOS pathways in Metaplastic Breast Cancer (MBC)
7/8/23 → 6/30/28
Project: Federal Funding Agencies
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
Emotions, Immunology and Breast Cancer: A Pilot Study
Project: Clinical Trial
-
Functional analysis and therapeutic potential of miR-708 in triple-negative metastatic breast cancer
9/30/13 → 9/29/16
Project: Federal Funding Agencies
-
Genome sequencing in triple negative breast cancer uncovers response to neoadjuvant chemotherapy
3/5/14 → 9/4/15
Project: Non Profit
-
Identification of novel immune targets and neoantigens for development of immunotherapy for breast cancer
Wang, R., Chang, J. C. & Liu, X.
12/1/16 → 11/30/19
Project: State
-
Imaging the mechanical microenvironment in cancers using ultrasound
3/1/20 → 2/29/24
Project: Federal Funding Agencies
-
Katherine, B50, for Treatment of Adjuvant HER2 Positive Breast Cancer
Chang, J. C., Niravath, P. A. & Singh, M.
Project: Clinical Trial
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Chang, J. C., Niravath, P. A. & Singh, M.
3/20/14 → …
Project: Clinical Trial